-
2024-511296-15-00
5
Musculoskeletal diseases
-
2024-515602-34-01
11
Hyperactive thyroid nodules
-
2025-524229-41-00
5
Triple negative breast cancer
-
2025-525068-13-00
4
Chronic Kidney Disease
-
2025-522038-29-00
5
2026-06-16
Locally advanced, unresected (unresectable or medically inoperable or
-
2024-517700-12-00
5
2025-12-10
Rectal cancer
-
2024-516652-18-00
5
2025-10-10
Atherosclerotic cardiovascular disease (ASCVD) and obesity or overweig
-
2025-521158-40-00
4
2025-09-12
oesophageal cancer
-
2024-513255-32-00
10
2025-07-03
Advanced gastric cancer
-
2024-514730-21-00
5
2025-07-01
Bacterial infections and mycoses
-
2024-517423-40-00
5
2025-06-23
Metastatic Castration-Resistant Prostate Cancer
-
2024-514850-59-00
5
2025-02-24
Appendicitis
-
2024-516939-28-00
4
2024-10-28
metastatic castration-resistant prostate cancer
-
2023-504144-33-01
11
2024-10-17
esophageal cancer
-
2023-506115-17-00
5
2024-10-14
Metastatic Colorectal Cancer
-
2024-516414-38-00
11
2024-10-01
Cancer
-
2024-514210-12-00
5
2024-09-01
polymyalgia rheumatica
-
2023-505377-32-00
5
2024-08-15
Diffuse large B-cell lymphoma (DLBCL)
-
2024-513363-15-01
11
2024-07-22
(Chronic) Peripheral (occlusive) arterial disease (PAD)
-
2023-508586-33-00
5
2024-05-14
multiple myeloma
-
2023-506698-36-00
5
2024-02-02
low-volume metastatic castration-sensitive prostate cancer
-
2023-509142-35-00
6
2024-01-29
Atrial fibrillation after stress (e.g., noncardiac surgery or acute me
-
2024-513570-22-00
5
2023-04-28
Morbid obesity
-
2023-508389-13-00
5
2022-11-08
Combined endpoint of all-cause mortality, kidney failure, and hospital